Conversely, CPT1A and SIRT1 protein levels and AMPKα phosphorylation were substantially decreased in the NASH group but were restored following APE, silymarin, and luteolin treatment. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatohepatitis.